Skip to main content

Advertisement

SpringerLink
Log in

Radioguided occult lesion localization for locally recurrent thyroid carcinoma

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The aim of this study was to present our experiences with patients operated on for the recurrence of papillary thyroid cancer with the combined use of preoperative ultrasonographic mapping and radioguided occult lesion localization (ROLL). Twenty patients who had already undergone total thyroidectomy and central/lateral neck dissection for papillary thyroid carcinoma were reoperated on due to locoregional metastasis. The patients with proven recurrences and high Tg wash-out levels in cytopathologic aspirates were operated on. For each patient, numbers of marked and non-marked lesions, and the metastatic and total numbers of marked/non-marked and non-mentioned lesions in the maps were recorded. Thirty-four of 40 (85%) lesions removed with ROLL were found to be malignant. In addition to the marked lesions during mapping, 60 additional lesions had been defined as suspicious. Fifty-six of these lesions were found at exact anatomic sites and localizations described and removed. Of 56 lesions, 36 (64%) were found to be metastatic. During postoperative follow-up, chylous leak with spontaneous regression in 7 days and seroma occurred in one patient. Radioguided occult lesion localization and preoperative mapping contribute to the safety and comfort of patients in planned reoperations on lateral and central neck regions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mazzaferri EL, Kloos RT (2001) Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447–1463

    Article  CAS  PubMed  Google Scholar 

  2. Coburn M, Teates D, Wanebo HJ (1994) Recurrent thyroid cancer: role of surgery versus radioactive iodine (131I). Ann Surg 6:587–595

    Article  Google Scholar 

  3. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428

    Article  CAS  PubMed  Google Scholar 

  4. Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Yuen KT, Law CC, Lau WH (2002) Follicular thyroid carcinoma: prognostic factors and the role of radioiodine. Cancer 95:488–498

    Article  PubMed  Google Scholar 

  5. Coburn M, Teates D, Wanebo HJ (1994) Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131). Ann Surg 219:587–593

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Bin Yousef HM, Alzahrani AS, Al Sobhi SS (2004) Preoperative neck ultrasonographic mapping for recurrent/persistent papillary thyroid cancer. World J Surg 28:1110–1114

    Article  Google Scholar 

  7. Alzahrani AS, Raef H, Sultan A, Al Sobhi S, Ingemansson S, Ahmed M, Al Mahfouz A (2002) Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer. J Endocrinol Invest 25:526–531

    Article  CAS  PubMed  Google Scholar 

  8. Maxon HR III, Englaro EE, Thomas SR, Hertzberg VS, Hinnefeld JD, Chen LS, Smith H, Cummings D, Aden MD (1992) Radioiodine-131 therapy for well-differentiated thyroid cancer—a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 33:1132–1136

    PubMed  Google Scholar 

  9. Grebe SK, Hay ID (1996) Thyroid cancer nodal metastases. The biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5:43–63

    CAS  PubMed  Google Scholar 

  10. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, Mciver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214

    Article  PubMed  Google Scholar 

  11. Kim MK, Mandel SH, Baloch Z, Livolsiv A, Langer JE, Didonato L, Fish S, Weber RS (2004) Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130:1214–1216

    Article  PubMed  Google Scholar 

  12. Salvatore M, Ruffini V, Reale F (2003) Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer. World J Surg 27:770–775

    Article  Google Scholar 

  13. Gulec SA, Eckert M, Woltering EA (2002) Gamma probe-guided lymph node dissection (gamma picking) in differentiated thyroid carcinoma. Clin Nucl Med 27:859–861

    Article  PubMed  Google Scholar 

  14. Agrawal A, Hall NC, Ringel MD, Povoski SP, Martin EW Jr (2008) Combined use of perioperative TSH stimulated (18) F-FDG PET/CT imaging and gamma probe radioguided surgery to localize and verify resection of iodine scan-negative recurrent thyroid carcinoma. Laryngoscope 118:2190–2194

    Article  PubMed  Google Scholar 

  15. Rubello D, Salvatori M, Casara D, Piotto A, Toniato A, Gross MD, Al-Nahhas A, Muzzio PC, Pelizzo MR (2007) 99 mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer. Eur J Surg Oncol 33:902–906

    Article  CAS  PubMed  Google Scholar 

  16. Tukenmez M, Erbil Y, Barbaros U, Dural C, Salmaslioglu A, Aksoy D, Mudun A, Ozarmağan S (2007) Radio-guided nonpalpable metastatic lymph node localization in patients with recurrent thyroid cancer. J Surg Oncol 96:534–538

    Article  PubMed  Google Scholar 

  17. Priven I, Schwartz A, Yeh H (2003) Ultrasonographic localization and marking of a small recurrent thyroid papillary carcinoma. Thyroid 13:663

    Article  CAS  PubMed  Google Scholar 

  18. Kuna SK, Bracic I, Tesic V, Kuna K, Herceg GH, Dodig D (2006) Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer. J Ultrasound Med 25:1531–1537

    Article  PubMed  Google Scholar 

  19. Ilgan S, Oztürk E, Yildiz R, Emer O, Ayan A, Görgülü S, Alagöz E, Deveci S, Ozgüven MA, Tufan T (2010) Combination of preoperative ultrasonographic mapping and radioguided occult lesion localization in patients with locally recurrent/persistent papillary thyroid carcinoma: a practical method for central compartment reoperations. Clin Nucl Med 35:847–852

    Article  PubMed  Google Scholar 

  20. Martino A, Monaco L, Golia R, Miletto P, Capasso P, Lombardi C, De Chiara G, Iannace C, Basagni C, Caracciolo F (2010) A new radioguided procedure for localization and surgical treatment of neck node metastasis of papillary thyroid cancer. J Endocrinol Invest 33:339–342

    Article  CAS  PubMed  Google Scholar 

  21. Jung YS, Kim SK, Park I, Ryu J, Kim SW, Lee CY, Lee J (2014) Surgical targeting of recurrent thyroid cancer using a novel mixture of 99m-technetium macroaggregated albumin and indocyanine green. Surg Innov 21:622–629

    Article  PubMed  Google Scholar 

  22. Borsò E, Grosso M, Boni G, Manca G, Bianchi P, Puccini M, Arganini M, Cabria M, Piccardo A, Arlandini A, Orlandini C, Mariani G (2013) Radioguided occult lesion localization of cervical recurrences from differentiated thyroid cancer: technical feasibility and clinical results. J Nucl Med Mol Imaging 57:401–411

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Ankara Oncology Training and Research Hospital, Angora Evleri Ressamlar Caddesi F6 Blok No 8, Beysukent, 06800, Ankara, Turkey

    Mehmet Ali Gulcelik, Niyazi Karaman, Lutfi Dogan, Gokhan Giray Akgul & Yavuz Selim Kahraman

  2. Department of Nuclear Medicine, Ankara Oncology Training and Research Hospital, Ankara, Turkey

    Ilgın Sahiner & Gulin Ucmak Vural

Authors
  1. Mehmet Ali Gulcelik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Niyazi Karaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lutfi Dogan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ilgın Sahiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gokhan Giray Akgul
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yavuz Selim Kahraman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gulin Ucmak Vural
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Niyazi Karaman.

Ethics declarations

Conflict of interest

Authors Mehmet Ali Gulcelik, Niyazi Karaman, Lutfi Dogan, Ilgın Sahiner, Gokhan Giray Akgul, Yavuz Selim Kahraman, and Gulin Ucmak Vural declare that they have no conflict of interest.

Ethical approval

Due to retrospective nature of the study, this article does not contain any additional studies with human participants performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gulcelik, M.A., Karaman, N., Dogan, L. et al. Radioguided occult lesion localization for locally recurrent thyroid carcinoma. Eur Arch Otorhinolaryngol 274, 2915–2919 (2017). https://doi.org/10.1007/s00405-017-4563-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-017-4563-2

Keywords

Search

Navigation